SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-059356
Filing Date
2024-03-05
Accepted
2024-03-05 16:44:11
Documents
16
Period of Report
2024-03-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d792997d8k.htm   iXBRL 8-K 31161
2 EX-4.3 d792997dex43.htm EX-4.3 20308
  Complete submission text file 0001193125-24-059356.txt   220007

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA snse-20240305.xsd EX-101.SCH 3870
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snse-20240305_def.xml EX-101.DEF 14095
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE snse-20240305_lab.xml EX-101.LAB 23424
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snse-20240305_pre.xml EX-101.PRE 15128
18 EXTRACTED XBRL INSTANCE DOCUMENT d792997d8k_htm.xml XML 5603
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39980 | Film No.: 24721499
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)